BioSpectrum Asia Partner with us
BioSpectrum Asia
Editorial Calendar

2027

Twelve issues. Twelve Asian markets in the spotlight. One region, seen through a global lens.

Download the calendar (PDF)Explore month by month
12Monthly themes
12Country spotlights
12Editor-hosted podcasts
12Sponsorable webinars
Ankit Kankar, Chief Operating Officer, BioSpectrum Asia
Ankit KankarChief Operating Officer, BioSpectrum Asia
Our readers want evidence, not noise. Our partners want a seat in conversations that matter.
Foreword

Twenty years of telling Asia's story. Now let's write the next one together.

When BioSpectrum Asia started out twenty years ago, the region's life sciences story was mostly told from somewhere else. Asia was where medicines were made at lower cost, where trials were run quickly and where multinationals opened sales offices. BioSpectrum Asia was built on a simple conviction: there was a different story to tell, about Asian science, Asian companies and Asian ambition. Every issue we have published since has come back to that belief.

In 2026 we marked our 20th year, and it felt less like an anniversary than a turning point. The region we cover has changed beyond recognition. Asian biotechs now license their molecules to the world's largest pharmaceutical companies. Singapore, Korea, India and China are building the capacity that global supply chains depend on. Regulators across the region are rewriting their rulebooks to move faster. Simply reporting on that shift is no longer enough.

So we have been transforming too. We launched the APAC Bioeconomy Index, the region's own benchmark of how scientific capability turns into commercial value. We introduced The BioSpectrum Asia 100 to recognise the companies shaping the industry by influence rather than size. We built digital editions that let readers explore a full issue online, turned our podcast into a weekly habit, added on-demand webinars, and are launching a multimedia explainer series for the suppliers who power this industry. Behind all of it is one idea: our readers want evidence, not noise, and our partners want a seat in conversations that matter.

The 2027 calendar in your hands is the result. Twelve issues, each with a clear theme, a Country Spotlight and a Global Lens, and formats built so your expertise reaches the people making decisions across Asia-Pacific.

My personal invitation is simple. Find the month, the market or the format where your story belongs, and talk to us early. The best partnerships we have built were never just media buys. They were collaborations where our editors and our partners created something the industry genuinely wanted to read. I would love for 2027 to be the year we build one together.

Ankit Kankar
Ankit KankarChief Operating Officer, BioSpectrum Asia
Welcome to 2027

A year of proof, not promise

Asia-Pacific no longer waits for the rest of the world to set the agenda in life sciences. It licenses assets to the West, builds the plants others depend on, and runs a growing share of the world's clinical trials. For 2027, BioSpectrum Asia follows that shift issue by issue.

Every month pairs a main theme with a Country Spotlight on one Asian market and a Global Lens on North America or Europe. Around that run sit the formats partners use most: a whitepaper and an industry report in every issue, a new Reader's Spotlight newsletter, twelve podcasts, twelve webinars, a fourteen-part country report series and two signature specials.

The region's decision-makers read BioSpectrum Asia to see what is actually being delivered. In 2027, that is exactly what we will measure.
The architecture

How every issue is built

Six building blocks run through all twelve issues, so a partner can own one slot all year or follow a single theme across every format.

01

Main Theme

One market-moving theme per issue, timed to the conferences and budget cycles the industry already plans around.

02

Country Spotlight

A different Asian market every month, from Singapore in January to Hong Kong SAR in December.

03

Global Lens

A North America or Europe angle in every issue, tracking how Western policy and deal flow land in Asia.

04

Whitepaper

One sponsorable whitepaper per issue, developed around the month's theme and promoted as a gated download.

05

Industry Report

One data-led report per issue, feeding the 2027 country report series.

06

Reader's Spotlight

A new monthly newsletter driven by readers: votes, nominations and questions the editor answers.

12 podcastsEditor-hosted episodes with a partner expert as guest
12 webinarsTraditional, Express and On Demand formats
14 country reportsTwelve Asian markets plus North America and Europe
2 signature specialsAPAC Bioeconomy Index 2027 and The BioSpectrum Asia 100
2027 at a glance

Twelve issues, one year

Select any month to open its full plan.

Twelve markets, one region

A different market every month

Each issue puts one Asian market under the spotlight: its policy, capital, capacity and the companies setting the pace. Select a number to open that month.

010203040506070809101112
Global Lens: North AmericaJan, Apr, May, Jun, Aug, Dec
Global Lens: EuropeFeb, Mar, Jul, Sep, Oct, Nov, Dec
January to December 2027

The monthly calendar

Each month pairs a main theme with a cover story, a Country Spotlight, a Global Lens and a set of partner-ready formats.

01
January 2027 · Main theme

APAC 2027: The Capital, Capacity and Policy Outlook

Country SpotlightSingapore

We open BioSpectrum Asia's 21st year with the region's scorecard: where money, manufacturing and regulation are moving, and which markets are set to pull ahead.

Cover story

The 2027 Outlook: 21 APAC CEOs on the bets they are making this year

01Where capital is flowing: funding, IPO windows and the sectors investors favour in 2027
02Capacity and cost: the manufacturing and talent bets CEOs are making, market by market
03Policy watch: the regulatory and trade moves that will decide who pulls ahead
Country Spotlight: Singapore
the regional HQ and biomanufacturing hub in a new growth cycle. RIE2030 priorities, Tuas and Biopolis capacity, and why global pharma still books its Asia command centre here.
Global Lens: North America
US pricing, tariff and onshoring signals, and what they mean for APAC partners and licensors.
Whitepaper
APAC Market Entry 2027: The Regional HQ Playbook

How Western life sciences firms choose between Singapore, Japan and Korea for their Asia base, with a decision grid on talent, tax, regulation and time to market.

Industry report
APAC Life Sciences Outlook 2027: funding, deals and capacity across 12 markets

Data-led analysis feeding the Singapore country report.

Reader's Spotlight
The 2027 Wishlist

Readers vote on the one policy change they want from APAC regulators this year; results published with editor commentary.

Timing hooks
J.P. Morgan Healthcare Conference (San Francisco); Asia Health Summit season

Plan launches, announcements and campaigns around these moments.

Podcast P01
The APAC Outlook Conversation
Hosted by the Chief Editor
Webinar W01
Scaling mAb Production with Single-Use Bioreactors
Upstream intensification, perfusion, scale-up risk
In the diary
J.P. Morgan Healthcare Conference (San Francisco); Asia Health Summit season
Ideal partners this issue
Investment promotion agencies, real estate and logistics firms, consultancies and CROs planning regional HQ and market-entry moves
02
February 2027 · Main theme

Bioprocessing Asia: Capacity, Continuous and Single-Use

Country SpotlightIndia

Biologics capacity is being built faster in Asia than anywhere else. We map who is building, with which technology, and where the bottlenecks now sit.

Cover story

The Capacity Race: inside Asia's new biologics plants

01Who is building: a plant-by-plant map of new biologics capacity across APAC
02Single-use or stainless: what operators actually chose, and why
03The new bottlenecks: talent, resins, media and utilities
Country Spotlight: India
CDMO and CRDMO expansion, the biosimilar export engine, BioE3 biomanufacturing hubs and the Western supply chain reset driving new orders.
Global Lens: Europe
how EU pharmaceutical legislation reform and the supply security agenda reshape outsourcing to Asian CDMOs.
Whitepaper
Single-Use at Scale: The Economics of Flexible Biomanufacturing in Asia

Total cost, speed to clinic and sustainability trade-offs of single-use versus stainless, with plant case studies from India, Korea and Singapore.

Industry report
Asia Biologics CDMO Capacity Report 2027

Data-led analysis feeding the India country report.

Reader's Spotlight
Plant of the Month

Reader-nominated biomanufacturing sites; the editor profiles the winning plant and its team.

Timing hooks
BioAsia (Hyderabad); BIO-Europe Spring build-up

Plan launches, announcements and campaigns around these moments.

Podcast P02
Capacity Talks
Hosted by the Editor, BioSpectrum Asia
Webinar W02
Cell Culture Media Optimisation for Biologics and Viral Vectors
Titer gains, chemically defined media, supply security
In the diary
BioAsia (Hyderabad); BIO-Europe Spring build-up
Ideal partners this issue
Bioprocess equipment, single-use, media and resin suppliers, and CDMOs building Asian capacity
03
March 2027 · Main theme

Cell and Gene Therapy: From Asian Trials to Asian Supply

Country SpotlightAustralia

Asia now runs a growing share of the world's cell and gene therapy trials. The next question is whether it can manufacture and pay for them.

Cover story

Living Medicines, Local Factories: who will make CGT for Asia?

01From trial to factory: where APAC CGT manufacturing capacity is coming online
02The cost problem: pricing, reimbursement and hospital-based manufacturing models
03Vector supply and automation as the make-or-break technologies
Country Spotlight: Australia
the fast-start clinical trial market, CGT manufacturing capacity, the R&D tax incentive and the pathway from phase 1 to US licensing deals.
Global Lens: Europe
ATMP regulation, hospital exemption debates and European CGT developers seeking APAC trial sites and partners.
Whitepaper
Viral Vector Supply in APAC: Closing the Manufacturing Gap

Capacity, quality and cost of AAV and lentiviral vector production across the region, and what developers should demand from suppliers.

Industry report
APAC Cell and Gene Therapy Landscape 2027: trials, plants and reimbursement

Data-led analysis feeding the Australia country report.

Reader's Spotlight
Women Leading Science

Timed to International Women's Day: readers nominate women leaders in APAC life sciences for a spotlight edition.

Timing hooks
BIO-Europe Spring; International Women's Day (8 March)

Plan launches, announcements and campaigns around these moments.

Podcast P03
Living Medicines
Hosted by the Editor, BioSpectrum Asia
Webinar W03
Automated Closed Systems for CAR-T and Next-Gen Cell Therapy
Closed processing, point-of-care manufacturing
In the diary
BIO-Europe Spring; International Women's Day (8 March)
Ideal partners this issue
CGT tools and automation providers, viral vector CDMOs and cryogenic logistics specialists
04
April 2027 · Main theme

Clinical Trials Asia: Speed, Sites and Regulatory Reliance

Country SpotlightJapan

Sponsors are rebalancing global trials towards Asia. We look at which countries deliver patients, data quality and approval speed.

Cover story

Trial Nation: how Asia became the world's clinical workhorse

01The speed league table: trial start-up times and enrolment rates by market
02Regulatory reliance and joint reviews that are cutting approval timelines
03What sponsors now demand from APAC sites on data quality and patient diversity
Country Spotlight: Japan
closing the drug loss gap, PMDA reforms to attract first-in-Asia trials, and regenerative medicine conditional approvals.
Global Lens: North America
FDA acceptance of Asian trial data, diversity requirements and what US sponsors want from APAC sites.
Whitepaper
Designing Multi-Regional Trials for Asia: A Sponsor's Guide

Site selection, ethnic sensitivity data, reliance pathways and decentralised elements that cut timelines in APAC trials.

Industry report
APAC Clinical Trials Index 2027: site capacity, start-up times and approval speed by market

Data-led analysis feeding the Japan country report.

Reader's Spotlight
Ask the Regulator

Readers submit questions on APAC approvals; answered by regulatory experts in a Q&A edition.

Timing hooks
CPHI Japan (Tokyo); AACR Annual Meeting

Plan launches, announcements and campaigns around these moments.

Podcast P04
Trial Nation
Hosted by the Editor, BioSpectrum Asia
Webinar W04
Decentralised and Hybrid Trials in APAC
eConsent, remote monitoring, local regulation
In the diary
CPHI Japan (Tokyo); AACR Annual Meeting
Ideal partners this issue
CROs, eClinical and data platforms, site networks and regulatory consultancies
05
May 2027 · Main theme

AI in R&D: From Pilot to Pipeline

Country SpotlightSouth Korea

Every life sciences company now has an AI pilot. Few have an AI-discovered product in the clinic, the lab or the market. We separate delivery from promise across Asia, from drug discovery to diagnostics, protein design and synthetic biology.

Cover story

Proof, Not Promise: Asia's AI discovery scorecard across the life sciences

01The scorecard: AI-discovered drugs, proteins, diagnostics and biologics from APAC, and how far each has progressed
02Beyond pharma: AI-led discovery in diagnostics, synthetic biology, biomanufacturing and agri-bio
03Partnering models between life sciences companies, tech majors and AI-native biotechs
Country Spotlight: South Korea
the K-Bio AI strategy, Samsung and Celltrion scale, data-rich hospitals and Korea's push into AI-enabled discovery partnerships.
Global Lens: North America
US AI discovery deal flow, big tech in life sciences and FDA thinking on AI in drug development.
Whitepaper
AI-Ready Labs: Data Foundations for Discovery in APAC

What it takes to make lab and clinical data usable for AI: standards, infrastructure, governance and cross-border data rules.

Industry report
APAC AI in Life Sciences Report 2027: platforms, deals and discoveries

Data-led analysis feeding the South Korea country report.

Reader's Spotlight
The AI Tool I Actually Use

Readers share the AI tools changing their daily work in labs and regulatory teams; the editor curates the best.

Secondary analysis
The Data Question

Separate secondary analysis: where Asia's AI training data comes from, including hospitals, biobanks and national data programmes, and the cross-border rules that decide who can use it.

Podcast P05
Proof Not Promise
Hosted by the Chief Editor
Webinar W05
AI-Driven Target Discovery: Data, Models and Validation
Knowledge graphs, generative chemistry, wet-lab validation
Timing hooks
BIO KOREA (Seoul); Bio-IT World
Ideal partners this issue
Cloud, AI and computing platforms, discovery software firms and scientific data providers
06
June 2027 · Main theme

Dealmaking Asia: Out-Licensing, Biologics and ADCs

Country SpotlightChina

Asian-origin assets are now a routine source of Western pipelines. We track the deals, the modalities and the terms.

Cover story

Made in Asia, Licensed to the World: the new pipeline map

01The numbers: H1 out-licensing volume, upfront payments and modality mix
02Why ADCs, bispecifics and metabolic assets lead the Western shopping list
03NewCo structures and geopolitics: how cross-border deals are being redesigned
Country Spotlight: China
out-licensing volume, ADC and bispecific leadership, NMPA speed, and how geopolitics is shaping deal structures.
Global Lens: North America
BIO International Convention read-out, US buyers' appetite for Asian assets and the BIOSECURE effect on partnering.
Whitepaper
Structuring Cross-Border Licensing Deals from Asia

Deal structures, NewCo models, diligence red flags and how Asian biotechs can protect value when licensing West.

Industry report
APAC Licensing and Partnering Report 2027 (H1 edition)

Data-led analysis feeding the China country report.

Reader's Spotlight
Deal of the Half-Year

Readers vote on the most significant APAC partnering deal of H1; the editor explains the winner.

Timing hooks
BIO International Convention; CPHI China (Shanghai); ASCO

Plan launches, announcements and campaigns around these moments.

Podcast P06
The Deal Desk
Hosted by the Chief Editor
Webinar W06
ADC Manufacturing and High-Potency Containment
Conjugation, containment, analytics
In the diary
BIO International Convention; CPHI China (Shanghai); ASCO
Ideal partners this issue
CDMOs, law firms, investment banks, deal advisers and partnering platforms
07
July 2027 · Main theme

Sustainability: Net Zero, Water and Green Chemistry

Country SpotlightTaiwan

Buyers now audit carbon as closely as quality. We ask which APAC plants can meet the sustainability terms written into global supply contracts.

Cover story

Greener by Design: can APAC biomanufacturing reach net zero?

01Where the emissions sit: energy, water, solvents and single-use plastics
02What buyers now demand: Scope 3 reporting and supplier sustainability clauses
03Plants getting it right: renewable power, water recycling and green chemistry case studies
Country Spotlight: Taiwan
semiconductor-grade manufacturing discipline applied to bio, green factory standards, CDMO ambitions and the policy push around BIO Asia-Taiwan.
Global Lens: Europe
CSRD sustainability reporting, the EU Green Deal and what European buyers now require from Asian suppliers.
Whitepaper
Net Zero Biomanufacturing: A Decarbonisation Roadmap for APAC Plants

Energy, water, solvent and single-use plastic reduction levers, with the cost and payback of each and a supplier reporting checklist.

Industry report
APAC Biopharma Sustainability and Net Zero Report 2027

Data-led analysis feeding the Taiwan country report.

Reader's Spotlight
Green Wins

Readers share one sustainability change that worked in their plant or lab; the editor features the most replicable ideas.

Timing hooks
BIO Asia-Taiwan (Taipei); mid-year ESG reporting cycle

Plan launches, announcements and campaigns around these moments.

Podcast P07
Index Insights
Hosted by the Chief Editor
Webinar W07
Rapid Microbial and Viral Safety Testing with NGS
Adventitious agent testing, release timelines
In the diary
BIO Asia-Taiwan (Taipei); mid-year ESG reporting cycle
Ideal partners this issue
Energy, automation and water technology firms, sustainable bioprocess suppliers and ESG advisers
08
August 2027 · Main theme

Supply Chain Resilience: Cold Chain, Logistics and Tariff Reality

Country SpotlightMalaysia

Tariffs, onshoring and temperature-sensitive biologics have turned logistics into a boardroom topic. We map the new routes.

Cover story

The New Routes: how APAC pharma is rewiring its supply chain

01Tariff exposure mapped by market and product category
02The new routes: China plus one, ASEAN hubs and onshoring commitments
03Cold chain for biologics and CGT: capacity, cost and the most common failure points
Country Spotlight: Malaysia
halal pharmaceuticals, contract manufacturing growth, medical device exports and the Penang and Kulim industrial corridors.
Global Lens: North America
US tariff exposure, the Section 232 aftermath and onshoring commitments, and what they mean for APAC exporters.
Whitepaper
Cold Chain 2027: Protecting Biologics and CGT in Transit Across APAC

Packaging, monitoring, lane qualification and last-mile risk for high-value temperature-sensitive products.

Industry report
APAC Pharma Supply Chain and Tariff Exposure Report 2027

Data-led analysis feeding the Malaysia country report.

Reader's Spotlight
Lessons from the Loading Dock

Readers share one supply chain failure and what fixed it; the best are published anonymously with expert notes.

Timing hooks
Mid-year tariff reviews; ASEAN pharma regulatory meetings

Plan launches, announcements and campaigns around these moments.

Podcast P08
Beyond the Cold Chain, Season 2
Hosted by the Editor, BioSpectrum Asia
Webinar W08
Temperature-Controlled Logistics for Biologics and CGT
Lane qualification, cryogenic shipping, data loggers
In the diary
Mid-year tariff reviews; ASEAN pharma regulatory meetings
Ideal partners this issue
Health logistics and cold chain providers, air cargo carriers, packaging firms and trade agencies
09
September 2027 · Main theme

Lab of the Future: Automation, Analytics and Quality

Country SpotlightThailand

Labs are becoming data factories. We look at the instruments, software and skills that decide speed and compliance.

Cover story

The Automated Lab: what Asia's fastest labs do differently

01What the fastest labs automate first, and the productivity gains they report
02Data integrity and compliance in the digital lab
03The new lab workforce: skills, training and retention
Country Spotlight: Thailand
the Bio-Circular-Green economy model, EEC biotech zones, medical hub ambitions and lab infrastructure growth around Thailand LAB.
Global Lens: Europe
GMP Annex 1 in practice, lab sustainability standards and European instrument makers' Asia strategies.
Whitepaper
Contamination Control After Annex 1: A Practical APAC Guide

Cleanroom strategy, environmental monitoring and quality risk management for sterile manufacturers across the region.

Industry report
APAC Laboratory and Analytical Technology Market Report 2027

Data-led analysis feeding the Thailand country report.

Reader's Spotlight
Show Us Your Lab

Readers submit photos and stories of lab upgrades; the editor features the most inventive set-ups.

Timing hooks
Thailand LAB INTERNATIONAL (Bangkok); ESMO build-up

Plan launches, announcements and campaigns around these moments.

Podcast P09
Inside the Lab
Hosted by the Editor, BioSpectrum Asia
Webinar W09
Contamination Control Strategy under Annex 1
Cleaning validation, environmental monitoring, disinfection
In the diary
Thailand LAB INTERNATIONAL (Bangkok); ESMO build-up
Ideal partners this issue
Analytical instrument, lab automation, LIMS and contamination control companies
10
October 2027 · Main theme

Infectious Disease and Biosecurity

Country SpotlightVietnam

Pandemic preparedness has moved from emergency response to industrial policy. We track Asia's vaccine makers, the AMR fight and biosecurity rules.

Cover story

Ready Next Time? Asia's vaccine and biosecurity readiness check

01Regional manufacturing capacity: who can make vaccines in Asia today
02AMR: the pipeline, the incentives and the regional response
03Biosecurity rules and what they mean for research collaboration and trade
Country Spotlight: Vietnam
local vaccine manufacturing, technology transfer partnerships, pharma law reforms and a fast-growing clinical and consumer health market.
Global Lens: Europe
WHO pandemic agreement follow-through, CEPI and Gavi funding, and European vaccine alliances in Asia.
Whitepaper
Regional Vaccine Manufacturing: Building Capacity That Lasts

Tech transfer, fill-finish, regulatory maturity and financing models that keep vaccine plants viable between outbreaks.

Industry report
APAC Vaccines and Infectious Disease Report 2027

Data-led analysis feeding the Vietnam country report.

Reader's Spotlight
The Outbreak That Taught Us Most

Readers reflect on the lesson that changed their organisation's preparedness; editor synthesis.

Timing hooks
BioJapan (Yokohama); World Health Summit; CPHI Worldwide build-up

Plan launches, announcements and campaigns around these moments.

Podcast P10
Ready Next Time
Hosted by the Editor, BioSpectrum Asia
Webinar W10
Lab Automation and Digital Data Integrity
LIMS, ELN, robotics, ALCOA+ compliance
In the diary
BioJapan (Yokohama); World Health Summit; CPHI Worldwide build-up
Ideal partners this issue
Vaccine developers, fill-finish and primary packaging suppliers, and global health funders
11
November 2027 · Main theme

Precision Medicine, Genomics and Diagnostics

Country SpotlightIndonesia

Population genomics programmes are turning Asia into the world's largest source of new genetic data. We ask who turns it into care.

Cover story

The Asian Genome Dividend: from sequencing to treatment

01National genome programmes compared: scale, funding and data access
02From sequence to prescription: companion diagnostics and reimbursement
03Data governance and the rules for cross-border genomic data sharing
Country Spotlight: Indonesia
the national genomics initiative, local manufacturing rules, halal certification and a market of 280 million patients.
Global Lens: Europe
BIO-Europe read-out, the European Health Data Space and diagnostics regulation lessons for Asian markets.
Whitepaper
Population Genomics in APAC: From Data to Clinical Value

How national sequencing programmes can feed diagnostics, drug discovery and reimbursement, with data governance models.

Industry report
APAC Precision Medicine and Diagnostics Report 2027

Data-led analysis feeding the Indonesia country report.

Reader's Spotlight
Rising Stars 2027

Readers nominate early-career scientists and founders; the shortlist feeds the December issue.

Timing hooks
BIO-Europe; MEDICA (Dusseldorf); CPHI Worldwide

Plan launches, announcements and campaigns around these moments.

Podcast P11
The Genome Dividend
Hosted by the Editor, BioSpectrum Asia
Webinar W11
mRNA and Vaccine Fill-Finish at Speed
Lipid nanoparticles, aseptic filling, cold chain
In the diary
BIO-Europe; MEDICA (Dusseldorf); CPHI Worldwide
Ideal partners this issue
Sequencing, diagnostics and bioinformatics companies, and precision medicine platforms
12
December 2027 · Main theme

Outlook 2028: Capital, Markets and the Next Growth Wave

Country SpotlightHong Kong SAR

We close the year by testing January's predictions against what happened, then map the forces that will shape APAC life sciences in 2028.

Cover story

Outlook 2028: the ten forces that will reshape APAC life sciences

01The 2027 scorecard: how January's predictions played out
02Capital, pricing and trade: the macro forces shaping 2028
03The growth markets to watch and where the next wave of investment will land
Country Spotlight: Hong Kong SAR
biotech listings, capital markets recovery, the Greater Bay Area and cross-border clinical data initiatives.
Global Lens: North America and Europe
the West's 2028 outlook on pricing, trade and dealmaking, and what APAC leaders should prepare for.
Whitepaper
Before the Books Close 2027: Ten Decisions for APAC CEOs

The annual executive whitepaper on the capital, portfolio and talent calls to make before year-end.

Industry report
APAC Life Sciences Year in Review 2027 and Outlook 2028

Data-led analysis feeding the Hong Kong SAR country report.

Reader's Spotlight
Readers' Story of the Year

Readers vote on the most important BioSpectrum Asia story of 2027; the editor explains why it mattered.

Timing hooks
ASH Annual Meeting; year-end budget cycle; J.P. Morgan 2028 build-up

Plan launches, announcements and campaigns around these moments.

Podcast P12
The 100 Conversations
Hosted by the Chief Editor
Webinar W12
Multi-Omics and Spatial Biology in Translational Research
Sequencing, proteomics, biomarker discovery
In the diary
ASH Annual Meeting; year-end budget cycle; J.P. Morgan 2028 build-up
Ideal partners this issue
Exchanges, investment agencies, science parks, banks and multinational pharma leadership teams
New monthly newsletter

Reader's Spotlight

A newsletter that puts readers at the centre: they vote, nominate and ask, and the editor responds. Each edition carries one exclusive partner slot with a native placement, a partner-supplied question or poll, and a results mention in the next edition.

JAN · EDITION 01

The 2027 Wishlist

Readers vote on the one policy change they want from APAC regulators this year; results published with editor commentary.

FEB · EDITION 02

Plant of the Month

Reader-nominated biomanufacturing sites; the editor profiles the winning plant and its team.

MAR · EDITION 03

Women Leading Science

Timed to International Women's Day: readers nominate women leaders in APAC life sciences for a spotlight edition.

APR · EDITION 04

Ask the Regulator

Readers submit questions on APAC approvals; answered by regulatory experts in a Q&A edition.

MAY · EDITION 05

The AI Tool I Actually Use

Readers share the AI tools changing their daily work in labs and regulatory teams; the editor curates the best.

JUN · EDITION 06

Deal of the Half-Year

Readers vote on the most significant APAC partnering deal of H1; the editor explains the winner.

JUL · EDITION 07

Green Wins

Readers share one sustainability change that worked in their plant or lab; the editor features the most replicable ideas.

AUG · EDITION 08

Lessons from the Loading Dock

Readers share one supply chain failure and what fixed it; the best are published anonymously with expert notes.

SEP · EDITION 09

Show Us Your Lab

Readers submit photos and stories of lab upgrades; the editor features the most inventive set-ups.

OCT · EDITION 10

The Outbreak That Taught Us Most

Readers reflect on the lesson that changed their organisation's preparedness; editor synthesis.

NOV · EDITION 11

Rising Stars 2027

Readers nominate early-career scientists and founders; the shortlist feeds the December issue.

DEC · EDITION 12

Readers' Story of the Year

Readers vote on the most important BioSpectrum Asia story of 2027; the editor explains why it mattered.

Audio series

Twelve conversations

One episode a month, hosted by the BioSpectrum Asia editorial team with a partner expert as guest. Take a single episode or a quarterly run.

P01JAN

The APAC Outlook Conversation

Where capital, capacity and policy are heading in 2027

Host: Chief Editor
Guest: Consultancy, bank or investment promotion agency
P02FEB

Capacity Talks

Biologics plant build-outs, single-use and continuous processing

Host: Editor, BioSpectrum Asia
Guest: Bioprocess supplier or CDMO
P03MAR

Living Medicines

Scaling cell and gene therapy manufacturing for Asian patients

Host: Editor, BioSpectrum Asia
Guest: CGT tools company or CDMO
P04APR

Trial Nation

Running faster, more diverse clinical trials in Asia

Host: Editor, BioSpectrum Asia
Guest: CRO or eClinical platform
P05MAY

Proof Not Promise

What AI has really delivered in life sciences discovery

Host: Chief Editor
Guest: Tech or AI platform
P06JUN

The Deal Desk

Out-licensing from Asia: terms, trends and traps

Host: Chief Editor
Guest: Law firm, bank or licensing buyer
P07JUL

Index Insights

Unpacking the APAC Bioeconomy Index 2027 results

Host: Chief Editor
Guest: Index Presenting Partner
P08AUG

Beyond the Cold Chain, Season 2

Logistics, tariffs and temperature control for biologics

Host: Editor, BioSpectrum Asia
Guest: Logistics or packaging company
P09SEP

Inside the Lab

Automation, analytics and data integrity

Host: Editor, BioSpectrum Asia
Guest: Instrument or lab software company
P10OCT

Ready Next Time

Vaccines, AMR and biosecurity in Asia

Host: Editor, BioSpectrum Asia
Guest: Vaccine maker or global health funder
P11NOV

The Genome Dividend

Turning population genomics into care

Host: Editor, BioSpectrum Asia
Guest: Sequencing or diagnostics company
P12DEC

The 100 Conversations

Leaders from the BioSpectrum Asia 100 on what comes next

Host: Chief Editor
Guest: BSA 100 Presenting Partner
Technology webinars

Twelve topics, ready to sponsor

One technology webinar a month, aligned to the issue theme and tailored to your launch calendar.

Traditional WebinarLive, moderated, full promotion
Webinar ExpressShorter live format, fast turnaround
On Demand WebinarRecorded, hosted and promoted
W01JAN

Scaling mAb Production with Single-Use Bioreactors

Upstream intensification, perfusion, scale-up risk

Bioreactor and upstream process suppliers
W02FEB

Cell Culture Media Optimisation for Biologics and Viral Vectors

Titer gains, chemically defined media, supply security

Cell culture media suppliers
W03MAR

Automated Closed Systems for CAR-T and Next-Gen Cell Therapy

Closed processing, point-of-care manufacturing

Cell therapy automation providers
W04APR

Decentralised and Hybrid Trials in APAC

eConsent, remote monitoring, local regulation

eClinical and CRO platforms
W05MAY

AI-Driven Target Discovery: Data, Models and Validation

Knowledge graphs, generative chemistry, wet-lab validation

Discovery AI and scientific data providers
W06JUN

ADC Manufacturing and High-Potency Containment

Conjugation, containment, analytics

ADC CDMOs and containment specialists
W07JUL

Rapid Microbial and Viral Safety Testing with NGS

Adventitious agent testing, release timelines

Biosafety testing laboratories
W08AUG

Temperature-Controlled Logistics for Biologics and CGT

Lane qualification, cryogenic shipping, data loggers

Health logistics and cold chain providers
W09SEP

Contamination Control Strategy under Annex 1

Cleaning validation, environmental monitoring, disinfection

Contamination control and cleanroom suppliers
W10OCT

Lab Automation and Digital Data Integrity

LIMS, ELN, robotics, ALCOA+ compliance

Lab instrument and informatics companies
W11NOV

mRNA and Vaccine Fill-Finish at Speed

Lipid nanoparticles, aseptic filling, cold chain

Fill-finish and primary packaging suppliers
W12DEC

Multi-Omics and Spatial Biology in Translational Research

Sequencing, proteomics, biomarker discovery

Sequencing and multi-omics platforms
Whitepaper and report opportunities

The country report series

Twelve Asian country reports, one for each spotlight month, plus two global reports on North America and Europe.

Jan
Singapore

Biomanufacturing and Regional HQ Report

Investment agencies, real estate and logistics firms

Feb
India

CDMO and Biosimilars Export Report

CDMOs and bioprocess suppliers

Mar
Australia

Clinical Trials and CGT Report

Trial networks, CROs and CGT developers

Apr
Japan

Drug Loss and Market Entry Report

Market-entry advisers, CROs and regulatory consultancies

May
South Korea

Bio AI and CDMO Report

Investment agencies, CDMOs and AI platforms

Jun
China

Out-Licensing and Innovation Report

Law firms, banks and licensing buyers

Jul
Taiwan

Green Manufacturing and Bio-Semiconductor Report

Industry bodies, green manufacturing and automation firms

Aug
Malaysia

Halal Pharma and Manufacturing Report

Industrial development agencies and contract manufacturers

Sep
Thailand

BCG Economy and Medical Hub Report

Investment boards, economic zones and lab suppliers

Oct
Vietnam

Pharma Market and Vaccines Report

Vaccine makers, distributors and law firms

Nov
Indonesia

Genomics and Local Manufacturing Report

Pharma manufacturers and diagnostics firms

Dec
Hong Kong SAR

Biotech Capital Markets Report

Exchanges, investment agencies and science parks

Jun
Aug
North America (Global)

US Market Access and Tariff Report for APAC Exporters

Logistics firms, law firms and trade offices

Jul
Nov
Europe (Global)

Europe Entry and Partnering Report for APAC Biotechs

European investment agencies and innovation clusters

Beyond the issue

Special projects

Franchise properties that sit above the monthly calendar, each with its own partnership model.

Mar

Women Leading APAC Life Sciences

Curated list and spotlight edition timed to International Women's Day, with a podcast mini-series.

Presenting partner plus profile features
Apr and Oct

Premium Edition 2027

Twice-yearly flagship content hub bundling the year's best analysis, with gated downloads and a dedicated eDM run.

Content syndication, lead generation
Year-round

APAC Event Coverage Series

On-ground and digital coverage packages for Asia Bio Partnering Forum, BIO KOREA, BIO Asia-Taiwan, Thailand LAB and BioJapan.

Media partner and booth-interview packages
Quarterly

Executive Roundtables, Singapore

Closed-door executive forums in Singapore, one per quarter, aligned to the issue theme and published as a short insight report.

Host partner, report output
Dec

Rising Stars 2027

Early-career scientists and founders, reader-nominated through the November Reader's Spotlight.

Talent and investor partners
Dec

Before the Books Close 2027

Annual executive whitepaper on ten year-end decisions for APAC CEOs.

Consulting or banking partner
Signature specials

Two editions the industry cites

Published outside the monthly run, each with its own launch moment, digital hub and partnership programme.

Special 01 · July 2027

APAC Bioeconomy Index 2027

Standalone special report, launching July 2027

The second edition of BioSpectrum Asia's region-native benchmark, published as a standalone special report outside the monthly issue run. Twelve markets, six weighted pillars and a senior executive survey, with year two turning the 2026 baseline into a trend line.

12Markets
6Pillars
900+Executives (2026)
8pt2026 gap
Partnership tiers
Presenting Partner1 (exclusive)
Title credit on the report, cover and landing page; foreword; seat on the launch webinar panel; full report lead list; podcast episode; year-round logo on the Index hub
Pillar PartnersUp to 6
One per Index pillar; named pillar chapter with expert commentary; pillar data sidebar; co-branded pillar webinar or article
Country PartnersUp to 12
One per market; branded country scorecard page; country report launch; local media amplification
Knowledge or Data Partner1 to 2
Methodology or data contribution credit; co-authored chapter; speaker slot
Launch Event Partner1
Hosts the July launch (virtual or at BIO Asia-Taiwan); branding across launch coverage and the on-demand replay
2027 timeline
Jan to FebSponsor sign-ups open; methodology refresh on the six weighted pillars
Mar to MayExecutive survey fieldwork across 12 markets (target 900+ respondents, matching 2026)
JunData close, scoring and year-on-year Capability Realisation Gap analysis
JulLaunch in the July issue, with landing page, launch webinar and podcast
Aug to DecCountry scorecard roll-out, pillar articles, event presentations and 2028 edition sign-ups
Special 02 · December 2027

The BioSpectrum Asia 100

Standalone collector's edition, December 2027

The second edition of the region's influence-led company ranking, published as a standalone collector's edition alongside the December issue. Scored on six weighted pillars with an evidence-tied methodology and a strict commercial firewall.

How companies are scored
Scientific and Pipeline20%
Commercial Growth20%
Regulatory15%
Manufacturing15%
Capital and Deals15%
Regional Leadership15%
  • Evidence-tied scoring; multinationals scored on APAC activity only
  • Standalone special edition with its own print run, digital hub and reveal event
  • Companion podcast series: The 100 Conversations
Partnership options
Presenting PartnerTitle credit across the edition, digital hub and reveal event
Category SponsorshipsOwn a pillar or sector category within the ranking
Badge LicensingOfficial BioSpectrum Asia 100 badge for listed companies
Reveal Event PartnerHost the December reveal and the on-demand replay
Partner with BioSpectrum Asia

Four ways in

Choose the level of ownership that fits your 2027 plan, from a single slot to a full signature special.

01

Own a month

A cover-month package: sponsored feature beside the cover story, print and digital display, a dedicated eDM and social amplification.

02

Own a slot all year

The same whitepaper, podcast, webinar or Reader's Spotlight slot across four or twelve issues for continuous visibility.

03

Own a market

The Country Spotlight plus the matching country report, ideal for investment agencies and regional headquarters.

04

Own a signature special

Presenting or category partnership on the APAC Bioeconomy Index 2027 or The BioSpectrum Asia 100.

Themes, report titles, webinar slots and event dates are indicative and may be refined as the 2027 conference and policy calendar firms up.

BioSpectrum Asia

Plan your 2027 with BioSpectrum Asia

Talk to us about owning a month, a market, a format or a signature special. Early partners choose first.

Partnership and editorial enquiries
coo@mmactiv.comcommunications@mmactiv.com

MM Activ Singapore Pte. Ltd.
1 North Bridge Road, #08-08 High Street Centre, Singapore 179094

Download the calendar (PDF)